🇺🇸 FDA
Patent

US 8715591

Microfluidic apparatus to control liposome formation

granted A61KA61K9/1277

Quick answer

US patent 8715591 (Microfluidic apparatus to control liposome formation) held by The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K9/1277